Interestingly, deficiency of AIM2 reduced the development of IMQ-induced psoriasis by decreasing the production of type 3 cytokines (such as IL-17A and IL-23) and infiltrating immune cells into the inflammatory site. Here, IL17A is linked to psoriasis.